EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Determining Risk Factors of Bleeding in Patients on Warfarin Treatment

Evren Uygungül, Cuneyt Ayrik, Huseyin Narci, Semra Erdoğan, Ibrahim Toker, Filiz Demir, Ulas Karaaslan

Advances in Hematology · 2014 · 2014 · 1-5

DOI: 10.1155/2014/369084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Hematology, 2014. Verfasst von Evren Uygungül und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Silifke State Hospital, Mersin, Turkey. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Warfarin is a commonly used oral anticoagulant agent. The most common adverse effects of warfarin are bleeding complications.

Methods

We performed a 1-year retrospective chart review of emergency department patients using warfarin. A total of 65 patients with bleeding disorder (study group) and 63 patients without bleeding (control group) were included, making up a total of 128 subjects. Demographic data, frequency of international normalized ratio (INR) checks, and routine blood results were extracted. Logistic regression analysis was used to determine which factors were most closely associated with bleeding complications.

Results

Median age was 62.0 ± 14.4 and 61.9 ± 14.5 for study group and control group, respectively. Educational status and frequency of INR checks were similar in both groups ( P = 0.101 and P = 0.483 , resp.). INR levels were higher in the study group ( 5.45 ± 3.98 versus 2.63 ± 1.71 , P < 0.001 ). Creatinine levels were also higher in the study group ( 1.14 ± 0.57 mg/dL versus 0.94 ± 0.38 mg/dL, P = 0.042 ). Acetylsalicylic acid use was more frequent in the study group and was associated with a 9-fold increase in bleeding complications ( P < 0.001 ) .

Conclusions

High INR levels, high creatinine levels, and acetylsalicylic acid use were associated with bleeding complications in ED patients using warfarin.

Autor:innen und Institutionen

  • Department of Emergency Medicine, Silifke State Hospital, Mersin, Turkey.
  • Department of Emergency Medicine, Faculty of Medicine, Mersin University, Mersin, Turkey.
  • Department of Biostatistics, Faculty of Medicine, Mersin University, Mersin, Turkey.
  • Department of Emergency Medicine, Tepecik Research Hospital, İzmir, Turkey.
  • Department of Emergency Medicine, State Hospital, Niğde, Turkey.
  • Department of Emergency Medicine, State Hospital, Balıkesir, Turkey.

Zitieren

APA

Uygungül, E., Ayrik, C., Narci, H., Erdoğan, S., Toker, I., Demir, F., & Karaaslan, U. (2014). Determining Risk Factors of Bleeding in Patients on Warfarin Treatment. Advances in Hematology, 2014, 1-5. https://doi.org/10.1155/2014/369084

Vancouver

Uygungül E, Ayrik C, Narci H, Erdoğan S, Toker I, Demir F, et al. Determining Risk Factors of Bleeding in Patients on Warfarin Treatment. Advances in Hematology. 2014;2014:1-5. doi:10.1155/2014/369084

BibTeX
@article{Uygungl2014,
  author = {Uygungül, Evren and Ayrik, Cuneyt and Narci, Huseyin and Erdoğan, Semra and Toker, Ibrahim and Demir, Filiz and Karaaslan, Ulas},
  title = {Determining Risk Factors of Bleeding in Patients on Warfarin Treatment},
  journal = {Advances in Hematology},
  year = {2014},
  volume = {2014},
  pages = {1--5},
  doi = {10.1155/2014/369084}
}
Kostenlos starten →